Cargando…

Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation

Phillygenin, as an active ingredient of Forsythia suspensa, possesses a wide range of biological and pharmacological activity. However, its development and application are restricted due to its poor bioavailability and low solubility. Our work aimed to develop a self-microemulsifying drug delivery s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingzhi, Yan, Wenrui, Tian, Yurun, Xue, Huanhuan, Tang, Jiankai, Zhang, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076376/
https://www.ncbi.nlm.nih.gov/pubmed/32028742
http://dx.doi.org/10.3390/pharmaceutics12020130
_version_ 1783507202289434624
author Wang, Lingzhi
Yan, Wenrui
Tian, Yurun
Xue, Huanhuan
Tang, Jiankai
Zhang, Liwei
author_facet Wang, Lingzhi
Yan, Wenrui
Tian, Yurun
Xue, Huanhuan
Tang, Jiankai
Zhang, Liwei
author_sort Wang, Lingzhi
collection PubMed
description Phillygenin, as an active ingredient of Forsythia suspensa, possesses a wide range of biological and pharmacological activity. However, its development and application are restricted due to its poor bioavailability and low solubility. Our work aimed to develop a self-microemulsifying drug delivery system to improve the oral bioavailability of phillygenin. The composition of the self-microemulsifying drug delivery system was preliminary screened by the pseudo-ternary phase diagram. Subsequently, the central composite design method was employed to optimize the prescription of the self-microemulsifying drug delivery system loaded with phillygenin. The prepared self-microemulsifying drug delivery system of phillygenin was characterized in terms of morphology, droplet size distribution, polydispersity index and stability. Then, the in vitro dissolution and the oral bioavailability were analyzed. The optimized self-microemulsifying drug delivery system of phillygenin consisted of 27.8% Labrafil M1944CS, 33.6% Cremophor EL, 38.6% polyethylene glycol 400 (PEG-400) and 10.2 mg/g phillygenin loading. The prepared self-microemulsifying drug delivery system of phillygenin exhibited spherical and uniform droplets with small size (40.11 ± 0.74 nm) and satisfactory stability. The in vitro dissolution experiment indicated that the cumulative dissolution rate of the self-microemulsifying drug delivery system of phillygenin was significantly better than that of free phillygenin. Furthermore, after oral administration in rats, the bioavailability of phillygenin was significantly enhanced by the self-microemulsifying drug delivery system. The relative bioavailability of the self-microemulsifying drug delivery system of phillygenin was 588.7% compared to the phillygenin suspension. These findings suggest that the self-microemulsifying drug delivery system of phillygenin can be a promising oral drug delivery system to improve the absorption of phillygenin.
format Online
Article
Text
id pubmed-7076376
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70763762020-03-24 Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation Wang, Lingzhi Yan, Wenrui Tian, Yurun Xue, Huanhuan Tang, Jiankai Zhang, Liwei Pharmaceutics Article Phillygenin, as an active ingredient of Forsythia suspensa, possesses a wide range of biological and pharmacological activity. However, its development and application are restricted due to its poor bioavailability and low solubility. Our work aimed to develop a self-microemulsifying drug delivery system to improve the oral bioavailability of phillygenin. The composition of the self-microemulsifying drug delivery system was preliminary screened by the pseudo-ternary phase diagram. Subsequently, the central composite design method was employed to optimize the prescription of the self-microemulsifying drug delivery system loaded with phillygenin. The prepared self-microemulsifying drug delivery system of phillygenin was characterized in terms of morphology, droplet size distribution, polydispersity index and stability. Then, the in vitro dissolution and the oral bioavailability were analyzed. The optimized self-microemulsifying drug delivery system of phillygenin consisted of 27.8% Labrafil M1944CS, 33.6% Cremophor EL, 38.6% polyethylene glycol 400 (PEG-400) and 10.2 mg/g phillygenin loading. The prepared self-microemulsifying drug delivery system of phillygenin exhibited spherical and uniform droplets with small size (40.11 ± 0.74 nm) and satisfactory stability. The in vitro dissolution experiment indicated that the cumulative dissolution rate of the self-microemulsifying drug delivery system of phillygenin was significantly better than that of free phillygenin. Furthermore, after oral administration in rats, the bioavailability of phillygenin was significantly enhanced by the self-microemulsifying drug delivery system. The relative bioavailability of the self-microemulsifying drug delivery system of phillygenin was 588.7% compared to the phillygenin suspension. These findings suggest that the self-microemulsifying drug delivery system of phillygenin can be a promising oral drug delivery system to improve the absorption of phillygenin. MDPI 2020-02-03 /pmc/articles/PMC7076376/ /pubmed/32028742 http://dx.doi.org/10.3390/pharmaceutics12020130 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Lingzhi
Yan, Wenrui
Tian, Yurun
Xue, Huanhuan
Tang, Jiankai
Zhang, Liwei
Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
title Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
title_full Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
title_fullStr Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
title_full_unstemmed Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
title_short Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
title_sort self-microemulsifying drug delivery system of phillygenin: formulation development, characterization and pharmacokinetic evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076376/
https://www.ncbi.nlm.nih.gov/pubmed/32028742
http://dx.doi.org/10.3390/pharmaceutics12020130
work_keys_str_mv AT wanglingzhi selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation
AT yanwenrui selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation
AT tianyurun selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation
AT xuehuanhuan selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation
AT tangjiankai selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation
AT zhangliwei selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation